Eye drops that can reverse poor vision? It may sound like science fiction, but one Israeli company is aiming to bring this product to market. The drops passed their Phase 2b clinical trial earlier this month, meaning they’ve proven to improve farsightedness, the inability to see or read nearby objects, and are highly tolerable.
Although results have yet to be released, Israel-based Orasis, Pharmaceuticals, revealed details last week about the latest results of the Phase 2b study for their CSF-1 eye drops. The drops offer temporary relief reversal of farsightedness. Their effects can be felt quickly, although they only last for a few hours.
